Calton & Associates’s Adient ADNT Stock Holding History

Calton & Associates’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-541	Closed	-$39K	–	356
2017 Q4	$39K	Buy	+541	New	+$43.6K	0.01%	740

Other funds holding ADNT

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return

LAM

Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Calton & Associates's ADNT Position: Q1 2018 in Review

Calton & Associates sold out of Adient (ADNT) in Q1 2018, closing a stake of 541 shares — an estimated $39K sold.

Calton & Associates first reported a position in ADNT in Q4 2017 and held it in 1 quarter. The position peaked at $39K in Q4 2017. 402 funds tracked by Wall St. Rank hold ADNT as of Q1 2018.

Calton & Associates reported no remaining Adient position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 541 Adient shares in Q1 2018, an estimated $39K.
Calton & Associates first reported a position in Adient in Q4 2017 and held it in 1 quarter.
Calton & Associates's Adient position peaked at $39K in Q4 2017.
402 funds tracked by Wall St. Rank held Adient as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.